TY  - GEN
AU  - Fenton,R T
AU  - Sznol,M
AU  - Luster,D G
AU  - Taub,D D
AU  - Longo,D L
TI  - A phase I trial of B7-transfected or parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401
SN  - 1043-0342
PY  - 1995///0505
KW  - Adult
KW  - Aged
KW  - Antigens, Neoplasm
KW  - immunology
KW  - Clinical Protocols
KW  - Female
KW  - Genetic Therapy
KW  - HLA-A1 Antigen
KW  - HLA-A2 Antigen
KW  - Humans
KW  - Immunity, Cellular
KW  - genetics
KW  - Male
KW  - Melanoma
KW  - Middle Aged
KW  - Transfection
KW  - Tumor Cells, Cultured
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
UR  - https://doi.org/10.1089/hum.1995.6.1-87
ER  -